Swarajya

Our View
HeadlinesMagazineVideosBooksस्वराज्यEconomyCultureEvents
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief
  • Subscriber login
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief

Lancet

Covaxin Phase 3 Trial Data Shows 77.8 Per Cent Efficacy Against Symptomatic COVID, Finds Study Published In Lancet
Covaxin Phase 3 Trial Data Shows 77.8 Per Cent Efficacy Against Symptomatic COVID, Finds Study Published In LancetSwarajya StaffNov 12, 2021 10:05 AM +05:30 IST
Serum Institute's Chairman Cyrus Poonawalla Bats For Booster Dose Of Covishield After Six Months
Serum Institute's Chairman Cyrus Poonawalla Bats For Booster Dose Of Covishield After Six MonthsSwarajya StaffAug 14, 2021 12:27 PM +05:30 IST
Pfizer COVID-19 Vaccine Produces Less Antibodies Against Delta Variant Of Coronavirus, Finds Study Published In Lancet
Pfizer COVID-19 Vaccine Produces Less Antibodies Against Delta Variant Of Coronavirus, Finds Study Published In LancetIANSJun 4, 2021 02:38 PM +05:30 IST
Tracing The Origin Question Of Coronavirus And Associated Controversies
Tracing The Origin Question Of Coronavirus And Associated ControversiesAlok BhattMay 21, 2021 08:00 PM +05:30 IST
Covid-19 Origins And Obfuscations: Those Who Preach About Keeping 'Science At Heart' Must Follow Their Own Advice
Covid-19 Origins And Obfuscations: Those Who Preach About Keeping 'Science At Heart' Must Follow Their Own AdviceSujeet MishraMay 17, 2021 11:04 AM +05:30 IST
Bharat Biotech Covaxin Safe, Generates Immune Response Against COVID-19: Study Published In British Medical Journal Lancet
Bharat Biotech Covaxin Safe, Generates Immune Response Against COVID-19: Study Published In British Medical Journal LancetSwarajya StaffJan 22, 2021 05:28 PM +05:30 IST
Sputnik V: Russian Covid-19 Vaccine Developers Respond To Criticism Of Clinical Trial Data In Medical Journal Lancet
Sputnik V: Russian Covid-19 Vaccine Developers Respond To Criticism Of Clinical Trial Data In Medical Journal LancetSwarajya StaffSep 19, 2020 12:58 PM +05:30 IST
Coronavirus: Triple Drug Antiviral Therapy Shows Promise For Treating Covid-19 Patients In Clinical Trial
Coronavirus: Triple Drug Antiviral Therapy Shows Promise For Treating Covid-19 Patients In Clinical TrialIANSMay 9, 2020 02:04 PM +05:30 IST
India Gains Four Spots In Global Human Capital Rankings By Institute for Health Metrics and Evaluation
India Gains Four Spots In Global Human Capital Rankings By Institute for Health Metrics and Evaluation Swarajya StaffSep 26, 2018 10:41 AM +05:30 IST
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Advertise
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype